Track Record

Julius Clinical Research has built a strong successful track record in the performance of phase II-IV clinical trials. Our expertise covers both investigator initiated trials and industry sponsored trials, from single country to global multi-center studies. Our established global network enables Julius Clinical Research to work with key opinion leaders throughout the world in key therapeutic areas.

Expertise
Julius Clinical Research has conducted trials across many different therapeutic areas, and considerable expertise lies in four main therapeutic areas:

• Infectious Diseases
• Cardiovascular Diseases
• Metabolic Diseases (Diabetes Mellitus, Obesity)
• CNS (Neurological and Psychiatric Disorders)

Julius Clinical Research has experience with and access to a range of cardiovascular imaging technologies, notably ultrasound, MRI, and PET scanning. We run a world-class core lab for ultra sonographic assessment of arterial wall thickness in randomised studies.

Julius Clinical Research and its partners have recruited over 200.000 patients in randomised clinical trials and are currently recruiting in diverse clinical studies. We have been the partner of many pharmaceutical and biotech companies. Julius Clinical Research has also proven to be a solid partner in product development for small and medium size R&D departments.  

Julius Clinical Research has access to thousands of investigators worldwide. The Principal Investigators affiliated with Julius Clinical Research and the Julius Center for Health Sciences and Primary Care have published some 3.000 articles in peer reviewed journals in the last decade.

Examples of recently performed studies  >